Market Research Report
Europe Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
|Europe Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027|
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 160 Pages
Delivery time: 3-5 business days
Europe alopecia treatment (hair loss) market is projected to register a CAGR of 6.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.
Europe Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Cicatricial Alopecia, Traction Alopecia and Others), Treatment (Localized Therapies, Systemic Therapies, Medical Devices and Herbal Treatment), Gender (Male and Female), Form (Oral, Topical and Parenteral), End User (Hospital, Home Healthcare and Dermatology Centers), Distribution Channel (Direct Tender, Retail Sales and Pharmacies), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe) Industry Trends and Forecast to 2027
Increase in prevalence of chemotherapy induced alopecia
Gerolymatos International SA
Taisho Pharmaceutical Holdings Co., Ltd.
Vita-Cos-Med Klett-Loch GmbH
Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)
Dr. Reddy's Laboratories Ltd.
Johnson & Johnson Services, Inc
Sun Pharmaceutical Industries Ltd.
Perrigo Company plc
Viviscal Limited (A Subsidiary of Church & Dwight Co.)
Dr. Kurt Wolff GmbH & Co. KG
Labo International S.r.l.
WON TECH Co., Ltd.